Inspire Medical Systems, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Inspire Medical Systems, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $2.19M, a 32.63% decline year-over-year.
- Inspire Medical Systems, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $3.25M, a 5.13% decline year-over-year.
- Inspire Medical Systems, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $3.43M, a 22.89% increase year-over-year.
- Inspire Medical Systems, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $2.79M, a 30.83% increase year-over-year.
- Inspire Medical Systems, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $5.02M, a 10.45% decline from fiscal 2024.
- Inspire Medical Systems, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $5.61M, a 5.77% increase from fiscal 2023.
- Inspire Medical Systems, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $5.30M, a 41.76% increase from fiscal 2022.
- Inspire Medical Systems, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $3.74M, a 7.66% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $2.19M 10-Q · filed 2026-08-03 | |
| 2025-12-31 | $5.02M 10-K · filed 2026-02-13 | |
| 2025-06-30 | $3.25M 10-Q · filed 2026-08-03 | |
| 2024-12-31 | $5.61M 10-K · filed 2026-02-13 | |
| 2024-06-30 | $3.43M 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $5.30M 10-K · filed 2026-02-13 | |
| 2023-06-30 | $2.79M 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $3.74M 10-K · filed 2025-02-10 | |
| 2022-06-30 | $2.13M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $3.47M 10-K · filed 2024-02-09 | |
| 2021-06-30 | $1.76M 10-Q · filed 2022-11-01 | |
| 2020-12-31 | $2.36M 10-K · filed 2023-02-10 | |
| 2020-06-30 | $1.06M 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $718.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.35M 10-K · filed 2022-02-15 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | |
| 2019-06-30 | $637.00K 10-Q · filed 2020-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |